Skip to content

Clinical trials

Amyloidosis, Familial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis, Familial Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20132
20141
20161
20194
20203
20211
20221
20234
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting8
Withdrawn3
Active, not recruiting3
Not yet recruiting2
Approved for marketing2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals10
Eidos Therapeutics, a BridgeBio company3
Boston University2
Intellia Therapeutics2
AstraZeneca1
Brigham and Women's Hospital1
Centre Hospitalier Universitaire de Nice1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Hospital de Alta Complejidad en Red1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis, Familial28
Amyloidosis17
Amyloid Neuropathies, Familial16
Amyloid Neuropathies8
Polyneuropathies8
Alzheimer Disease5
Cardiomyopathies4
Peripheral Nervous System Diseases3
Genetic Diseases, Inborn2
Heredodegenerative Disorders, Nervous System2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.